Search research articles
Contact Us
Filters
Showing results (91-100 of 166) with videos related to
Page
of 17
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 20, 2020
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
Tim R Cressey, Oraphan Siriprakaisil, Rachel W Kubiak, et al.
The Lancet. HIV
|
January 31, 2024
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
Adrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
The Lancet. HIV
|
July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies
Tom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
Clinical Pharmacokinetics
|
May 27, 2020
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Xiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Journal of Clinical Pharmacology
|
December 17, 2025
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure
Steven Sun, Mina Nikanjam, Mark Mirochnick, et al.
AIDS (London, England)
|
May 6, 2025
Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescents
Seef Abdalla, Alexandra Compagnucci, Alasdair Bamford, et al.
Journal of Clinical Pharmacology
|
January 11, 2016
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
Nontiya Homkham, Tim R Cressey, Lily Ingsrisawang, et al.
Plos Medicine
|
September 12, 2022
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study
Jean de Dieu Tapsoba, Jane Cover, Christopher Obong'o, et al.
Paediatric Drugs
|
October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions
Anne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
The Journal of Antimicrobial Chemotherapy
|
February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
Stein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 166) with videos related to
Sort By:
Page
of 17
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 20, 2020
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
Tim R Cressey, Oraphan Siriprakaisil, Rachel W Kubiak, et al.
The Lancet. HIV
|
January 31, 2024
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
Adrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
The Lancet. HIV
|
July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies
Tom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
Clinical Pharmacokinetics
|
May 27, 2020
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
Xiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Journal of Clinical Pharmacology
|
December 17, 2025
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure
Steven Sun, Mina Nikanjam, Mark Mirochnick, et al.
AIDS (London, England)
|
May 6, 2025
Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescents
Seef Abdalla, Alexandra Compagnucci, Alasdair Bamford, et al.
Journal of Clinical Pharmacology
|
January 11, 2016
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
Nontiya Homkham, Tim R Cressey, Lily Ingsrisawang, et al.
Plos Medicine
|
September 12, 2022
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study
Jean de Dieu Tapsoba, Jane Cover, Christopher Obong'o, et al.
Paediatric Drugs
|
October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions
Anne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
The Journal of Antimicrobial Chemotherapy
|
February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
Stein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
Page
of 17